These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 213345)

  • 1. Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.
    Francavilla A; Jones AF; Starzl TE
    Gastroenterology; 1978 Dec; 75(6):1026-32. PubMed ID: 213345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglucagonemia and altered responsiveness of hepatic adenylate cyclase-adenosine 3',5'-monophosphate system to hormonal stimulation during chronic ingestion of DL-ethionine.
    Craven PA; Derubertis FR
    Biochim Biophys Acta; 1977 Apr; 497(2):415-27. PubMed ID: 192313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone.
    Christoffersen T; Refsnes M; Brønstad GO; Ostby E; Huse J; Haffner F; Sand TE; Hunt NH; Sonne O
    Eur J Biochem; 1984 Jan; 138(2):217-26. PubMed ID: 6321168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cyclic AMP, insulin and glucose responses to glucagon stimulation in patients with liver cirrhosis according to the stage of development ].
    Esteva Díaz F; Ducóns García J; Ceña Lázaro G; Márquez Galván M; Juste Rullo G; Barrao Comps F
    Rev Clin Esp; 1986 Nov; 179(7):347-51. PubMed ID: 3025944
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for delayed development of the glucagon receptor of adenylate cyclase in the fetal and neonatal rat heart.
    Clark CM; Beatty B; Allen DO
    J Clin Invest; 1973 May; 52(5):1018-25. PubMed ID: 4349483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adenylate cyclase system in human liver: characterization, subcellular distribution and hormonal sensitivity in normal or cirrhotic adult, and in foetal liver.
    Pecker F; Duvaldestin P; Berthelot P; Hanoune J
    Clin Sci (Lond); 1979 Oct; 57(4):313-25. PubMed ID: 41665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of intravenous perfusion of glucagon on plasma concentrations of glucose, insulin and cyclic AMP in patients with hepatic cirrhosis].
    Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Valle Cagigas M; González Puerta C
    Rev Clin Esp; 1985 Oct; 177(5):209-11. PubMed ID: 3001846
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of glucagon on blood gastrin levels in hepatic cirrhosis: correlation with blood levels of cyclic AMP].
    Francavilla A; Sansonno D; Ierardi E; Amoruso A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2588-93. PubMed ID: 6258616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glucagon on plasma cyclic AMP and glucose concentrations in patients with alcoholic cirrhosis.
    Strange RC; Mjos OD; Henden T; Jynge P
    Acta Med Scand; 1977; 202(1-2):87-8. PubMed ID: 197799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.
    Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
    J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rapid changes of hepatic glycolytic enzymes and fructose-1,6-diphosphatase activities after intravenous glucagon in humans.
    Greene HL; Taunton OD; Stifel FB; Herman RH
    J Clin Invest; 1974 Jan; 53(1):44-51. PubMed ID: 4357616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased glucagon-stimulated cyclic AMP production by isolated liver cells of rats with type 2 diabetes.
    Portha B; Chamras H; Broer Y; Picon L; Rosselin G
    Mol Cell Endocrinol; 1983 Sep; 32(1):13-26. PubMed ID: 6313452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma.
    Bamonti-Catena F; Peracchi M; Conte D; Cantalamessa L; Lorenzano E; Orsatti A; Salerno F
    Clin Chem Lab Med; 1998 Sep; 36(9):709-14. PubMed ID: 9804395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cyclic adenosine-3', 5'-monophosphate response to glucagon in patients with liver disease.
    Davies TF; Prudhoe K; Douglas AP
    Br Med J; 1976 Apr; 1(6015):931-3. PubMed ID: 178399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative adenylate cyclase activities in homogenate and plasma membrane fractions of Morris hepatoma 5123tc (h).
    Hickie RA; Jan SH; Datta A
    Cancer Res; 1975 Mar; 35(3):596-600. PubMed ID: 163685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalous adenosine cyclic 3':5'-monophosphate responses to glucagon in patients with hepatocellular carcinoma.
    Pun KK; Ho PW; Yeung RT
    Cancer Res; 1986 Apr; 46(4 Pt 2):2152-4. PubMed ID: 3004721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal and hormone-stimulated adenylate cyclase in liver plasma membranes: measurement by radioimmunoassay of cyclic AMP.
    Rosselin G; Freychet P
    Biochim Biophys Acta; 1973 Apr; 304(2):541-51. PubMed ID: 4351079
    [No Abstract]   [Full Text] [Related]  

  • 18. Colchicine improves the alterations in the liver adenylate cyclase system of cirrhotic rats.
    Mourelle M; Rojkind M; Rubalcava B
    Toxicology; 1981; 21(3):213-22. PubMed ID: 6170133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
    Hendy GN; Tomlinson S; O'Riordan JL
    Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
    Shimamura J; Taketa K; Ide T; Nakata K; Nagashima H
    Acta Med Okayama; 1985 Oct; 39(5):385-96. PubMed ID: 3000142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.